about
Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial CarcinomaData set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Emerging therapeutic biomarkers in endometrial cancerNew concepts for an old problem: the diagnosis of endometrial hyperplasiaEndometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical DilemmasInsulin/IGF and sex hormone axes in human endometrium and associations with endometrial cancer risk factors.Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues.Estimated intermediate risk endometrial cancer: debate and new perspectives on therapy individualization and prognosis establishment starting from a peculiar case.The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.Signalling pathways in endometrial cancerPTEN: Multiple Functions in Human Malignant TumorsPrediction model for regional or distant recurrence in endometrial cancer based on classical pathological and immunological parametersPrognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer.PTEN expression in benign human endometrial tissue and cancer in relation to endometrial cancer risk factorsIdentifying aggressive forms of endometrioid-type endometrial cancer: new insights into molecular subtyping.ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.Long non-coding RNA derived miR-205-5p modulates human endometrial cancer by targeting PTEN.Molecular biology of gynecological cancer.Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium.MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer.MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2.The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and ReproducibilityIncreased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors.An update of the classical Bokhman's dualistic model of endometrial cancer.Mitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1.EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma.Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and Prognosis.TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.MDH2 Stimulated by Estrogen-GPR30 Pathway Down-Regulated PTEN Expression Promoting the Proliferation and Invasion of Cells in Endometrial Cancer.High expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.Heme, an essential nutrient from dietary proteins, critically impacts diverse physiological and pathological processes.HER2-positive endometrial cancer subtype carries poor prognosis.Regulation and roles of bicarbonate transporters in cancer.Current status of molecular biomarkers in endometrial cancer.Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations.Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma.The role of pathology in the management of patients with endometrial carcinoma.Downregulation of tyrosine threonine kinase inhibits tumor growth via G2/M arrest in human endometrioid endometrial adenocarcinoma.Pathology of Endometrial Carcinoma.Differential expression of ten-eleven translocation genes in endometrial cancers.
P2860
Q26797456-941EE03B-C7B8-4F01-A1FE-F2091A6F09DFQ26852127-E565E2B6-2E54-4EF2-843B-E4DCC0B7483EQ26865904-86290835-C5DA-4239-9A5B-D66D390AAFD9Q28071864-4A87FECE-445F-4F86-81B7-65783173A7BAQ28074769-96D0A6B8-3336-4D12-A65E-16350396FDC6Q30381117-0E2C0E8E-18DA-4AA0-BC3E-B439C631E86AQ33760113-FAF17738-466C-47B1-8214-A230D89A6EE3Q33802919-A558B1DA-EA2A-4EF6-81D0-43F15525DCAAQ34091442-2547B5A7-4AE6-475C-B25A-6AE3382A8F66Q34721660-D9D09378-A9FC-4912-AB0E-5465B269878AQ35087328-5C7DAF02-AC8A-41C2-BED4-EEE17D92B44DQ36027067-3E362A31-56FC-4C32-B1F6-9095D477A59AQ36162978-1E226D2E-4E3A-48DC-9D4B-5A709DB144D2Q36235829-EAAC6B4C-45ED-4FDA-AEB5-CF2071F08B0DQ36263947-A916E2A1-31DE-47B1-B70F-F32A1BFBF36CQ36372293-E2817169-70BE-4627-B630-7E54FCD8B11EQ36420288-2DD31034-CF43-49E4-B7F2-F4CE127FA4C2Q36502779-18846716-54BE-4CDE-9A77-D418A27B1BB6Q36738761-CCF6F72B-3E2C-4825-8EC3-EF7D7070021AQ36827700-A6343BDA-835E-4139-8EF4-82E9062EA4E6Q37029456-DC054016-E125-44EB-BC6D-1D9FF90E983CQ37068930-D18D97A4-FD27-49DC-B83F-7DEB9B807E17Q37082536-A0BF1717-E772-4EE1-8071-387BAB9984B0Q37195410-C9E54B27-E8CC-4DF5-ACCC-79D6049799B8Q37225495-E2F699EE-E7BE-4A1A-ACFC-EA6BBADD99F1Q37295470-476704EC-AE68-4239-ACC3-11E4DBAC60CAQ37360520-3B38B6E1-A6FE-4ED4-92F9-004BBEC90487Q37381834-62C0A900-47AE-4BE5-8C63-C069526BD5A0Q37634217-0C881169-9938-4151-A76F-D3F1BDEB6A0EQ37636282-1AFADD09-864D-4E4A-AEEF-C6D39FBFFD3AQ37666848-3B381B37-30C1-429A-94F3-C65D33EFD91DQ37700593-975F9085-B041-4B7F-BD4F-DBC6E59A4FE0Q37719006-C8A04A51-9330-4677-9F49-8A423240A559Q38234228-2D7E1081-8C6D-42F7-AAC0-3DA2E866A92EQ38267985-74726878-0616-4090-B8AB-0F5832DE7697Q38321607-62CB694E-AEFA-4C17-8E90-6133D09F6EC7Q38686652-74F74DC3-077C-4D30-81D5-91319D52B723Q38696992-114D89D3-33D4-4B9B-8366-AEC460358610Q38788207-6309D8C1-5246-44EA-8035-D4A1FDC98F29Q38871612-0B2B73C8-A95E-4D74-8F76-2D824C2538FF
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular pathology of endometrial carcinoma.
@en
type
label
Molecular pathology of endometrial carcinoma.
@en
prefLabel
Molecular pathology of endometrial carcinoma.
@en
P2860
P3181
P356
P1433
P1476
Molecular pathology of endometrial carcinoma.
@en
P2093
Jaime Prat
Xavier Matias-Guiu
P2860
P304
P356
10.1111/HIS.12053
P577
2013-01-01T00:00:00Z